First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The TORCH Randomized Trial

Cesare Gridelli, Francesco Perrone, Ciro Gallo et al.|Journal of Clinical Oncology|2012

Cited by 234